Suramin for autism in boys aged 5–14
Part of Mental health clinical trials.
This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Boys between 5 and 14 years old with an autism diagnosis
- Must have significant social difficulties, as measured by specific tests
- Non-verbal IQ above 70
- Must live within about 90 minutes of the study site in Orange County, CA
- Child and parent must speak English
- Must agree to use sunscreen and cover skin during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study is testing whether a probiotic supplement called Limosilactobacillus Reuteri might help reduce social difficulties in children with autism. It may offer a new way to support your child's social development.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.
Hear when a new Autism Spectrum Disorder (ASD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.